Last reviewed · How we verify

NCT06867614

Laparoscopic Versus Transvaginal Closure of the Vaginal Vault After Total Laparoscopic Hysterectomy

Recruiting now NA Last updated 10 March 2025
What this trial tests

NA trial testing Total laparoscopic hysterectomy in Total Laparoscopic Hysterectomy in 48 participants. Currently enrolling.

Timeline
14 January 2025
Primary endpoint
31 August 2025
19 January 2026

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposescreening
Enrollment48
Start date14 January 2025
Primary completion31 August 2025
Estimated completion19 January 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Eligibility, female only, with Total Laparoscopic Hysterectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to compare the laparoscopic and transvaginal closure techniques of the vaginal vault in patients who perform TLH, regarding the risk of vaginal vault hematoma and other complications as vaginal cuff infection and sexual dysfunction.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Proceedings of the 28th Ain Shams Obstetrics and Gynecology International Conference (ASOGIC), Cairo, Egypt, August 2025
    · 2025

Verify or expand the search:

Other trials of Total laparoscopic hysterectomy

Trials testing the same drug.

Other recruiting trials for Total Laparoscopic Hysterectomy

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06867614.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing